Allergic rhinitis is an inflammatory disorder of the nasal mucosa typified
by the symptoms of nasal itch, sneeze, anterior nasal secretions, and nasal
blockage. These symptoms arise from the interaction between mediators and
neural, vascular, and glandular structures within the nose. Nasal itch, sne
ezes, and rhinorrhoea are predominantly neural in origin, while nasal obstr
uction is predominantly vascular. Nasal biopsy studies show accumulation of
eosinophils within the lamina propria and epithelium and an increase in ti
ssue and cell surface basophils in both seasonal and perennial allergic rhi
nitis. These cells are in an activated state. Within the epithelium, increa
sed numbers of mast cells, T cells and Langerhans' cells, which induce T-ce
ll activation, are found. The accumulation of these cells can be linked to
chemokine and cytokine generation by the epithelial cells themselves. Thus,
the tissue cell. recruitment is orchestrated by activated mast cells, T ce
lls, and epithelial cells, with the recruited tissue eosinophils also contr
ibuting to their persistence at this site through autocrine mechanisms. Mas
t cells generate an array of mediators including histamine, tryptase, leuko
trienes, and prostaglandins. Histamine is also generated by basophils. Eosi
nophils and basophils contribute to the leukotriene synthesis within the ti
ssue. Histamine nasal insufflation induces nasal itch, sneeze, and rhinorrh
oea as well as nasal blockage, thereby reproducing all the symptoms of alle
rgic rhinitis. These effects are primarily mediated by H-1-receptors, and H
-1-receptor antagonists are a prominent treatment. Antagonism of histamine
at these receptors reduces symptoms by about 40-50%, with the greatest effe
ct on the neurally mediated responses. Thus, histamine is a major mediator
of allergic rhinitis, but not the sole contributor. Nasal insufflation with
leukotrienes, prostaglandins, or kinins is associated with the development
of nasal blockage. These mediators act primarily on the nasal vasculature
and, in this respect, leukotrienes are potent mediators. Leukotrienes also
induce plasma protein exudation, which contributes to the anterior nasal se
cretions. Studies with combination products have suggested that modifying t
he effects of both leukotrienes and histamine has complementary effects in
relieving nasal symptoms, indicating that both these mediators are relevant
to disease expression.